← Leaderboards
Akiko Maeda
Case Western Reserve University
$2,769,505
Attributed
$2,769,505
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $473.5K · FY2008–21$500K$375K$250K$125K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$2,769,505 · 3
By mechanism
R01$1,927,175 · 1
K08$429,952 · 1
P30$412,378 · 1
Top collaborators
No co-investigators on record.
Most similar at Case Western Reserve University
Same institution · by research overlap
- Robert Gerd Salomon$12,628,629
- James E Dennis$6,725,082
- Susie Suh$151,572
- Satish C Kalhan$4,841,409
Others in their field
Top investigators on “Vision”
- Chanza Baytop · Westat, Inc.$271,217,917
- Edward W Maly · United Nations Children'S Fund$264,005,699
- Eric J Barron · Pennsylvania State Univ University Park$243,972,016
- Antonio J Busalacchi · University Of Maryland, College Park$243,972,016
- Valerie Koch · University Corporation For Atmospheric Res$243,972,016
- Everette D Joseph · Howard University$243,972,016
Research focus
VisionBiologicalStargardt&AposAge Related Macular DegenerationRetinitis PigmentosaS DiseaseRetinalLeadRetinaResearch PersonnelRetinal DegenerationRetinal DiseasesRetinoidsScienceInhibitor/AntagonistMacular DegenerationVisualCell DeathPhysical CondensationPhotoreceptorsProductionPharmaceutical PreparationsMouse ModelMutation
Grant awards (16)
Molecular Biology and Genotyping Core$82,767
P30 · FY2021 · EY · contact PI
Molecular Biology and Genotyping Core$82,767
P30 · FY2020 · EY · contact PI
Molecular Biology and Genotyping Core$82,338
P30 · FY2019 · EY · contact PI
Molecular Biology and Genotyping Core$82,253
P30 · FY2018 · EY · contact PI
Molecular Biology and Genotyping Core$82,253
P30 · FY2017 · EY · contact PI
Reactive ocular aldehyde in degenerative retinal diseases$392,500
R01 · FY2016 · EY · contact PI
Reactive ocular aldehyde in degenerative retinal diseases$384,650
R01 · FY2015 · EY · contact PI
Reactive ocular aldehyde in degenerative retinal diseases$384,650
R01 · FY2014 · EY · contact PI
Reactive ocular aldehyde in degenerative retinal diseases$372,875
R01 · FY2013 · EY · contact PI
Reactive ocular aldehyde in degenerative retinal diseases$392,500
R01 · FY2012 · EY · contact PI
Retinal degeneration diseases and the visual retinoid cycle$81,000
K08 · FY2012 · EY · contact PI
Retinal degeneration diseases and the visual retinoid cycle$81,000
K08 · FY2011 · EY · contact PI
Retinal degeneration diseases and the visual retinoid cycle$81,000
K08 · FY2010 · EY · contact PI
Retinal degeneration diseases and the visual retinoid cycle$24,952
K08 · FY2010 · EY · contact PI
Retinal degeneration diseases and the visual retinoid cycle$81,000
K08 · FY2009 · EY · contact PI
Retinal degeneration diseases and the visual retinoid cycle$81,000
K08 · FY2008 · EY · contact PI